Management of Botulinum Toxin-Induced Blepharoptosis: A Comparative Review of Therapeutic Approaches
Brena-Ortiz Yoatzin *
Facultad de Medicina y Cirugía, Universidad Regional del Sureste, Av. Cto. 1 Nte., San Sebastian Tutla, 71323 El Rosario, Oaxaca, México.
García-Montalvo Iván Antonio
Facultad de Medicina y Cirugía, Universidad Regional del Sureste, Av. Cto. 1 Nte., San Sebastian Tutla, 71323 El Rosario, Oaxaca, México.
*Author to whom correspondence should be addressed.
Abstract
Palpebral blepharoptosis secondary to applying botulinum toxin type A is a common complication in dermatocosmetics worldwide. Although most cases resolve spontaneously, the process can be slow and generate high patient dissatisfaction. The treatment of this condition is complex due to its nature and the limitations in the therapeutic options available. This review article focuses on the mechanism of action of botulinum toxin, the pathophysiology of blepharoptosis, and prevention and treatment strategies for this complication. By better understanding the clinical and therapeutic aspects involved, we seek to improve the care and satisfaction of patients experiencing this complication.
Keywords: Palpebral ptosis, botulinum toxin type A, apraclonidine, brominidine, oxymetazoline, phenylephrine